Literature DB >> 3596639

Liposomes as adjuvants with immunopurified tetanus toxoid: influence of liposomal characteristics.

D Davis, G Gregoriadis.   

Abstract

The effect of various manipulations of liposomes composed of equimolar phospholipid and cholesterol on immune responses to the incorporated immunopurified tetanus toxoid was investigated in BALB/c mice. In studies designed to establish proper dosage for immunization and to reveal the roles of the liposomal phospholipid to toxoid mass ratio, gel-liquid crystalline transition temperatures (Tc) of the liposomal phospholipids and mode of antigen incorporation into liposomes on immune responses, animals were injected intramuscularly with various amounts of the toxoid, free, entrapped in multilamellar dehydration-rehydration vesicles (DRV) or covalently linked to the surface of multilamellar vesicles (MLV) prepared by the classical procedure. Two identical injections separated by 4 weeks were given and IgG1 and IgG2b antibodies specific for the toxoid assayed in sera by an enzyme-linked immunosorbent assay. Results suggest that the adjuvant effect of liposomes is improved considerably when liposomal phospholipid to toxoid mass ratios are as high as 2049:1; however, adjuvanticity is reduced to reach very low levels for much higher ratios (e.g. 90,361:1); antibody responses are similar for liposomes (phospholipid to toxoid mass ratios: 14.3-33.1) made of a variety of phospholipids with Tcs ranging from -32 degrees to 41.5 degrees but are low or non-existent when liposomes are made of distearoyl phosphatidylcholine (Tc, 54 degrees) (however, see Discussion); there are no differences in antibody responses between liposomes with entrapped and surface-linked toxoid.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3596639      PMCID: PMC1453375     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  Hepatitis B surface antigen-containing liposomes enhance humoral and cell-mediated immunity to the antigen.

Authors:  E K Manesis; C H Cameron; G Gregoriadis
Journal:  FEBS Lett       Date:  1979-06-01       Impact factor: 4.124

2.  Immunogenicity of liposomal model membranes.

Authors:  S C Kinsky
Journal:  Ann N Y Acad Sci       Date:  1978       Impact factor: 5.691

3.  Liposomes as immunological adjuvants.

Authors:  A G Allison; G Gregoriadis
Journal:  Nature       Date:  1974-11-15       Impact factor: 49.962

4.  [Inclusion of Gross virus cell surface associated antigen in liposomes].

Authors:  D Gerlier; F Sakai; J F Doré
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1978-02-06

5.  Liposomes in immunology: evidence that their adjuvant effect results from surface exposition of the antigens.

Authors:  N van Rooijen; R van Nieuwmegen
Journal:  Cell Immunol       Date:  1980-02       Impact factor: 4.868

6.  Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components.

Authors:  J Senior; G Gregoriadis
Journal:  Life Sci       Date:  1982-06-14       Impact factor: 5.037

7.  Liposomes as immunological adjuvants in eliciting antibodies specific to the synthetic polypeptide poly(LTyr, LGlu)-poly(DLAla)--(LLys) with high frequency of site-associated idiotypic determinants.

Authors:  R Lifshitz; C Gitler; E Mozes
Journal:  Eur J Immunol       Date:  1981-05       Impact factor: 5.532

8.  Presentation of an MuLV-related tumour antigen in liposomes as a potent tertiary immunogen after adoptive transfer.

Authors:  O Bakouche; D Gerlier
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

9.  Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes.

Authors:  Y Sanchez; I Ionescu-Matiu; G R Dreesman; W Kramp; H R Six; F B Hollinger; J L Melnick
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

10.  Liposomes as vehicles for vaccines.

Authors:  C R Alving; B Banerji; T Shiba; S Kotani; J D Clements; R L Richards
Journal:  Prog Clin Biol Res       Date:  1980
View more
  17 in total

Review 1.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 2.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

3.  The pharmacokinetics of, and humoral responses to, antigen delivered by microencapsulated liposomes.

Authors:  S Cohen; H Bernstein; C Hewes; M Chow; R Langer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

4.  Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory.

Authors:  G Gregoriadis; Z Wang; Y Barenholz; M J Francis
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

5.  The role of macrophages in the immunoadjuvant action of liposomes: effects of elimination of splenic macrophages on the immune response against intravenously injected liposome-associated albumin antigen.

Authors:  D Su; N Van Rooijen
Journal:  Immunology       Date:  1989-03       Impact factor: 7.397

Review 6.  Liposomal adjuvant development for leishmaniasis vaccines.

Authors:  Anis Askarizadeh; Mahmoud Reza Jaafari; Ali Khamesipour; Ali Badiee
Journal:  Ther Adv Vaccines       Date:  2017-11-15

7.  Immunogenicity of liposomes and iscoms containing the major outer membrane protein of Neisseria gonorrhoeae: influence of protein content and liposomal bilayer composition.

Authors:  G F Kersten; A M van de Put; T Teerlink; E C Beuvery; D J Crommelin
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

Review 8.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

Review 9.  Modulating the immune system through nanotechnology.

Authors:  Tamara G Dacoba; Ana Olivera; Dolores Torres; José Crecente-Campo; María José Alonso
Journal:  Semin Immunol       Date:  2017-10-09       Impact factor: 11.130

10.  Immunomodulation by liposome entrapped allergen.

Authors:  N Arora; S V Gangal
Journal:  Mol Cell Biochem       Date:  1990-09-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.